CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,750 | +7.3% | 1,052 | +32.7% | 0.00% | 0.0% |
| Q2 2023 | $44,519 | +150.5% | 793 | +101.8% | 0.00% | +100.0% |
| Q1 2023 | $17,775 | +118400.0% | 393 | +5.4% | 0.00% | 0.0% |
| Q4 2022 | $15 | -99.9% | 373 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $24,000 | +4.3% | 373 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $23,000 | -72.3% | 373 | -65.8% | 0.00% | -50.0% |
| Q4 2021 | $83,000 | +654.5% | 1,090 | +990.0% | 0.00% | – |
| Q3 2021 | $11,000 | -31.2% | 100 | 0.0% | 0.00% | – |
| Q2 2021 | $16,000 | -63.6% | 100 | -74.2% | 0.00% | -100.0% |
| Q1 2021 | $44,000 | – | 388 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |